Increased androgenic activity and breast cancer risk in premenopausal women

G. Secreto, P. Toniolo, F. Berrino, C. Recchione, S. Di Pietro, G. Fariselli, A. Decarli

Research output: Contribution to journalArticle

Abstract

Blood and urine specimens from 27 premenopausal breast cancer patients and 62 healthy controls have been compared with respect to concentration of testosterone and progesterone in blood and of testosterone and androstanediol in urine, measured in the luteal phase of the menstrual cycle. There was a strong positive association between the concentration of the two androgens, either in blood or urine, and breast cancer risk. A strong association was also observed with decreasing levels of progesterone. The association was statistically significant (p for trend less than 0.01) for each hormone; the rate ratios were 10.2 for serum testosterone (highest category), 5.6 for serum progesterone (lowest category), 8.4 for urinary testosterone (highest category), and 5.2 for androstanediol (highest category). The rate ratio for women presenting both high serum testosterone and low progesterone was 21.8 (4.1 to 116.1). Considering the exposure to at least one of three androgens at the highest level and low progesterone, the rate ratio was as high as 90.2 (8.2 to 989.7). This study provides evidence for the hypothesis that increased androgenic activity is an important risk indicator for breast cancer, particularly when associated with anovulation, as indicated by low serum progesterone level.

Original languageEnglish
Pages (from-to)5902-5905
Number of pages4
JournalCancer Research
Volume44
Issue number12 I
Publication statusPublished - 1984

Fingerprint

Progesterone
Testosterone
Breast Neoplasms
Urine
Serum
Androgens
Anovulation
Luteal Phase
Hormones

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Secreto, G., Toniolo, P., Berrino, F., Recchione, C., Di Pietro, S., Fariselli, G., & Decarli, A. (1984). Increased androgenic activity and breast cancer risk in premenopausal women. Cancer Research, 44(12 I), 5902-5905.

Increased androgenic activity and breast cancer risk in premenopausal women. / Secreto, G.; Toniolo, P.; Berrino, F.; Recchione, C.; Di Pietro, S.; Fariselli, G.; Decarli, A.

In: Cancer Research, Vol. 44, No. 12 I, 1984, p. 5902-5905.

Research output: Contribution to journalArticle

Secreto, G, Toniolo, P, Berrino, F, Recchione, C, Di Pietro, S, Fariselli, G & Decarli, A 1984, 'Increased androgenic activity and breast cancer risk in premenopausal women', Cancer Research, vol. 44, no. 12 I, pp. 5902-5905.
Secreto G, Toniolo P, Berrino F, Recchione C, Di Pietro S, Fariselli G et al. Increased androgenic activity and breast cancer risk in premenopausal women. Cancer Research. 1984;44(12 I):5902-5905.
Secreto, G. ; Toniolo, P. ; Berrino, F. ; Recchione, C. ; Di Pietro, S. ; Fariselli, G. ; Decarli, A. / Increased androgenic activity and breast cancer risk in premenopausal women. In: Cancer Research. 1984 ; Vol. 44, No. 12 I. pp. 5902-5905.
@article{107cdb7712bd4aba93b4070f56d48dff,
title = "Increased androgenic activity and breast cancer risk in premenopausal women",
abstract = "Blood and urine specimens from 27 premenopausal breast cancer patients and 62 healthy controls have been compared with respect to concentration of testosterone and progesterone in blood and of testosterone and androstanediol in urine, measured in the luteal phase of the menstrual cycle. There was a strong positive association between the concentration of the two androgens, either in blood or urine, and breast cancer risk. A strong association was also observed with decreasing levels of progesterone. The association was statistically significant (p for trend less than 0.01) for each hormone; the rate ratios were 10.2 for serum testosterone (highest category), 5.6 for serum progesterone (lowest category), 8.4 for urinary testosterone (highest category), and 5.2 for androstanediol (highest category). The rate ratio for women presenting both high serum testosterone and low progesterone was 21.8 (4.1 to 116.1). Considering the exposure to at least one of three androgens at the highest level and low progesterone, the rate ratio was as high as 90.2 (8.2 to 989.7). This study provides evidence for the hypothesis that increased androgenic activity is an important risk indicator for breast cancer, particularly when associated with anovulation, as indicated by low serum progesterone level.",
author = "G. Secreto and P. Toniolo and F. Berrino and C. Recchione and {Di Pietro}, S. and G. Fariselli and A. Decarli",
year = "1984",
language = "English",
volume = "44",
pages = "5902--5905",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "12 I",

}

TY - JOUR

T1 - Increased androgenic activity and breast cancer risk in premenopausal women

AU - Secreto, G.

AU - Toniolo, P.

AU - Berrino, F.

AU - Recchione, C.

AU - Di Pietro, S.

AU - Fariselli, G.

AU - Decarli, A.

PY - 1984

Y1 - 1984

N2 - Blood and urine specimens from 27 premenopausal breast cancer patients and 62 healthy controls have been compared with respect to concentration of testosterone and progesterone in blood and of testosterone and androstanediol in urine, measured in the luteal phase of the menstrual cycle. There was a strong positive association between the concentration of the two androgens, either in blood or urine, and breast cancer risk. A strong association was also observed with decreasing levels of progesterone. The association was statistically significant (p for trend less than 0.01) for each hormone; the rate ratios were 10.2 for serum testosterone (highest category), 5.6 for serum progesterone (lowest category), 8.4 for urinary testosterone (highest category), and 5.2 for androstanediol (highest category). The rate ratio for women presenting both high serum testosterone and low progesterone was 21.8 (4.1 to 116.1). Considering the exposure to at least one of three androgens at the highest level and low progesterone, the rate ratio was as high as 90.2 (8.2 to 989.7). This study provides evidence for the hypothesis that increased androgenic activity is an important risk indicator for breast cancer, particularly when associated with anovulation, as indicated by low serum progesterone level.

AB - Blood and urine specimens from 27 premenopausal breast cancer patients and 62 healthy controls have been compared with respect to concentration of testosterone and progesterone in blood and of testosterone and androstanediol in urine, measured in the luteal phase of the menstrual cycle. There was a strong positive association between the concentration of the two androgens, either in blood or urine, and breast cancer risk. A strong association was also observed with decreasing levels of progesterone. The association was statistically significant (p for trend less than 0.01) for each hormone; the rate ratios were 10.2 for serum testosterone (highest category), 5.6 for serum progesterone (lowest category), 8.4 for urinary testosterone (highest category), and 5.2 for androstanediol (highest category). The rate ratio for women presenting both high serum testosterone and low progesterone was 21.8 (4.1 to 116.1). Considering the exposure to at least one of three androgens at the highest level and low progesterone, the rate ratio was as high as 90.2 (8.2 to 989.7). This study provides evidence for the hypothesis that increased androgenic activity is an important risk indicator for breast cancer, particularly when associated with anovulation, as indicated by low serum progesterone level.

UR - http://www.scopus.com/inward/record.url?scp=0021738992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021738992&partnerID=8YFLogxK

M3 - Article

C2 - 6498847

AN - SCOPUS:0021738992

VL - 44

SP - 5902

EP - 5905

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 12 I

ER -